# FDA Inspection 1243015 - Biomat USA Inc. - June 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/eeea128b-763e-4da8-a8a0-868734cfc0ff
Source feed: FDA_Inspections

> FDA Inspection 1243015 for Biomat USA Inc. on June 28, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243015
- Company Name: Biomat USA Inc.
- Inspection Date: 2024-06-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1063223 - 2018-08-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d68781ad-9e74-4fa7-83ce-dd8428cf037a)
- [FDA Inspection 935765 - 2015-07-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cd221667-7691-4809-b320-2113cf3f4e07)
- [FDA Inspection 730999 - 2011-06-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f84565f0-8934-469b-9898-175aa321897f)

Company: https://www.keypedia.com/companies/biomat-usa-inc/fa41928e-e872-4233-a3a7-830507d5cda3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d